<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="activity_corpus\PMC7928042\results\search\activity\results.xml">
  <result pre="intestinal epithelial cells and primary human hepatocytes to trypsin-like serine" exact="protease inhibitors" post="with potential antiviral effect E. PÃ¡szti-Gere et al. https://orcid.org/0000-0003-4073-7018PÃ¡szti-GereErzsÃ©betahttps://orcid.org/0000-0001-6978-9626PomothyJuditahttps://orcid.org/0000-0002-3380-0827JerzseleÃ�kosahttps://orcid.org/0000-0002-6279-2491PilgramOliverbhttps://orcid.org/0000-0001-6523-4754SteinmetzerTorstenb[a],"/>
  <result pre="primary human hepatocytes to trypsin-like serine protease inhibitors with potential" exact="antiviral" post="effect E. PÃ¡szti-Gere et al. https://orcid.org/0000-0003-4073-7018PÃ¡szti-GereErzsÃ©betahttps://orcid.org/0000-0001-6978-9626PomothyJuditahttps://orcid.org/0000-0002-3380-0827JerzseleÃ�kosahttps://orcid.org/0000-0002-6279-2491PilgramOliverbhttps://orcid.org/0000-0001-6523-4754SteinmetzerTorstenb[a], Department of Pharmacology"/>
  <result pre="the membrane-bound host protease TMPRSS2. Keywords HIEC-6 PHH trypsin-like serine" exact="protease inhibitors" post="occludin H2O2 Funding Hungarian National Research, Development and Innovation"/>
  <result pre="as anticoagulants. A relatively non-specific scaffold of numerous trypsin-like serine" exact="protease inhibitors" post="comprises tertiary amides of arylsulfonylated 3-amidinophenylalanines (Phe(3-Am)), like tosyl-Phe(3-Am)-piperidide"/>
  <result pre="inhibitor WX-UK111 reached phase II development for cancer therapy. Several" exact="derivatives" post="of this scaffold have been developed as inhibitors of"/>
  <result pre="human hepatocytes (PHHs) to estimate the safety of these potential" exact="antiviral" post="agents inÂ vitro. Cell viability assays were performed to"/>
  <result pre="hepatocytes (PHHs) to estimate the safety of these potential antiviral" exact="agents" post="inÂ vitro. Cell viability assays were performed to determine"/>
  <result pre="24â€‰h. The cells were incubated at 37â€‰Â°C, with 5% CO2." exact="Inhibitors" post="MI-1900 and MI-1907 Inhibitors MI-1900 and MI-1907 were synthesised"/>
  <result pre="incubated at 37â€‰Â°C, with 5% CO2. Inhibitors MI-1900 and MI-1907" exact="Inhibitors" post="MI-1900 and MI-1907 were synthesised analogously to previously published"/>
  <result pre="to the subsequent procedures. Figure 1. Structures of the used" exact="protease inhibitors." post="MTS assay The assay is based on the ability"/>
  <result pre="mice and in Caco-2 cells treated with the broad-spectrum serine" exact="protease inhibitor," post="AEBSF or the selective synthetic matriptase inhibitor CVS-3983. Blocked"/>
  <result pre="were also measured by establishing the effects of 3,3â€²-diindolylmethane (DIM)" exact="antioxidant" post="agent on HIEC-651. Using MI-1900 and MI-1907, the extracellular"/>
  <result pre="their activities against TMPRSS2, camostat and a structurally related serine" exact="protease inhibitor," post="nafamostat are presently investigated as off-label administration in the"/>
  <result pre="ACE2 and TMPRSS2 and is blocked by a clinically proven" exact="protease inhibitor." post="Cell2020;181:271â€&quot;80.e8.32142651 16BestleD, HeindlMR, LimburgH, et al.TMPRSS2 and furin are"/>
  <result pre="treatment of human bronchial epithelial cells with serine and cysteine" exact="protease inhibitors" post="prevents severe acute respiratory syndrome coronavirus entry. J Virol2012;86:6537â€&quot;45.22496216"/>
 </snippets>
</snippetsTree>
